Loading...

477 posters, 14 topics, 2,065 authors, 1,055 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

The Joint EBJIS-MSIS 2026 Conference

17 - 19 September, 2026 | Porto, Portugal

The Joint EBJIS-MSIS 2026 Conference banner

PP55

A Comparative analysis of DAIR and Repeat Two-Stage Exchange in Recurrent Periprosthetic Joint Infections following Complex Revision Total Knee Arthroplasty

Part of Topic

Prosthetic Joint Infections

Introduction

Periprosthetic joint infection (PJI)I is the most common cause of failure in both primary and revision total knee arthroplasty (rTKA)[1], and is a significant source of mortality, morbidity, and healthcare expense [2]. Debridement, Antibiotics, and implant retention (DAIR) and two-stage exchange are common treatments for PJIs [3,4]. Two-stage exchange remains a common treatment strategy for  chronic PJI [5]; however, this approach may be suboptimal when implant removal complicates reconstruction or limits future reconstructive options.

Methods

Retrospective study of patients treated for recurrent TKA PJI from 2011-2022. Data collected through electronic medical records (EMR). Complex revision defined as use of metaphyseal sleeve, trabecular metal cone, or structural allograft. Patients stratified into two groups: Two-stage exchange with complex revision components or DAIR with long-term antibiotic suppression. Primary outcome: failure, defined as reoperation for PJI within 3 years (MSIS ORT Tier 3 or 4). Kaplan-Meier analysis used to evaluate failure rates
 

Results

Cohort: 40 patients included; 27 DAIR, 13 repeat two-stage exchange, mean follow-up 25.2 ± 14.2 for DAIR and 34.8 ± 31.0 months for two-stage exchange. Survival analysis revealed no significant difference in overall failure between DAIR and two-stage exchange (80.0% vs 64.1%, respectively, P = 0.23)
 

Conclusion

DAIR demonstrated a higher cumulative failure rate at 2 years, despite no significant difference in overall failure-free survival. Group size disparity likely reflects surgeon preference for managing complex cases. Larger studies needed to determine optimal treatment approach for recurrent PJI
ebjis-msis2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.